Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Basecamp Research launches ZymCTRL a world-first, open source, generative AI tool that designs enzymes for more sustainable industrial processes

This image opens in the lightbox

News provided by

Basecamp Research

18 Jun, 2024, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

ZymCTRL is the world's first open-source, text-based enzyme generation model and can be used across multiple industries, including therapeutics and sustainability initiatives.

AI model able to produce sequences that produced functional enzymes with desirable characteristics for industrial applications.

LONDON, June 18, 2024 /PRNewswire/ -- Basecamp Research, a world leader in artificial intelligence (AI)-based design of proteins and other biological systems, in partnership with the Ferruz Laboratory at the Institute of Molecular Biology of Barcelona today announced the release of ZymCTRL ("enzyme control"), a ChatGPT-like tool that generates new sequences from scratch based on a user simply typing in an enzyme identification code, which specifies the desired activity.

Continue Reading
This image opens in the lightbox
Basecamp Research field scientists collect samples during an expedition to Costa Rica on July 29, 2023. Basecamp Research is building the largest and most diverse foundational database, purpose-built for artificial intelligence models. Lab tests confirm Basecamp Research's more diverse database supercharges AI models like ZymCTRL to generate sequences that are richer and more robust for industrial use. (Photo courtesy of Basecamp Research)

Large language models (LLMs), such as ChatGPT, have proven useful in helping scientists design and generate protein sequences.. However, current models require further training as well as conditioning on a known protein starter sequence ("seed sequence") for protein generation.

ZymCTRL is a next-generation end-to-end protein LLM that offers rapid, cost-effective design capabilities for generating artificial enzymes. In contrast to other LLMs, the tool requires no seed sequence, giving end users complete control. Another important feature is ZymCTRL's ability to create enzyme sequences that work but share only 30% resemblance to those in the training set – expanding the possibilities for designing new enzymes.

"With ZymCtrl, generating highly specific enzymes is as easy as interacting with a chatbot", said Noelia Ferruz who has been partnering with Basecamp Research for over 2 years. The Ferruz lab is considered a pioneer in the field of AI for protein design, having previously built ProtGPT2. a deep unsupervised language model for protein design.

"Even before the release of ChatGPT,  we began working on large language models with Noelia because we think these models represent the future of biological research and protein design," said Dr. Philipp Lorenz, CTO of Basecamp Research. "We're deeply excited by these results and ZymCTRL's ability to create functional enzymes that can solve some of today's biggest challenges, from finding new ways to treat devastating diseases to building greener and more sustainable catalytic processes in bioindustry."

The open source ZymCTRL model has been independently reviewed by academics in Structural Biology and ChemBioChem, peer-reviewed scientific journals. In ChemBioChem, researchers at The Institute of Biochemistry at Austria's Graz University of Technology, cited ZymCTRL's efficiency and ease of use. "ZymCtrl designs putative enzyme variants on consumer GPUs within seconds and, remarkably, it creates these sequences with only an EC number as input," wrote Horst Lechner, principle investigator for the institute, which is focuses on enzyme design that differs from what's seen in nature.

Basecamp Research is sharing ZymCTRL open source with researchers and sees an array of potential applications, including designing enzymes for disease treatment and diagnostics, biofuel production, sustainable agriculture innovations and much more.

While ZymCTRL was initially trained on publicly available datasets, it can also be integrated with other datasets, including Basecamp Research's proprietary BaseGraph database, to further optimise the model and improve sequence outputs.

Highlights

  • ZymCTRL was first trained on the BRENDA enzyme database, comprising 37M enzyme sequences.
    - From this, the team generated sets of carbonic anhydrases, enzymes that accelerate the conversion of carbon dioxide to bicarbonate, helping capture and store CO2, and lactate dehydrogenases, enzymes that help convert sugar into energy in our cells, with no further fine-tuning for the AI model.
    After producing and purifying the proteins, several showed enzyme activity despite less than 40% of their sequences resembling proteins seen in the public database. This happened with no additional adjustments to the model.
    - To correct for potential biases in public databases, which have uneven sampling due a lack of biodiversity, ZymCTRL was adjusted using a wider range of lactate dehydrogenase sequences from Basecamp Research's proprietary BaseGraph dataset.
    - With this fine-tuning, the team created lactate dehydrogenases with higher quality scores in silico (in computer simulations), such as better predicted local distance difference test (pLDDT) values, compared to sequences generated with no prior training.
  • Remarkably, active enzymes continued to show significant activity at a high temperature of 45°C as well as across a broad pH range of 4.5 to 9.5 – meaning it can work or stay stable in slightly acidic to slightly basic environments – offering significant industry advantages over naturally-occurring lactate dehydrogenases. This excellent pH tolerance allows a single enzyme to be used in many different processes with different pH levels, making the enzyme very useful and adaptable for many applications.
  • Two of the artificial lactate dehydrogenase enzymes were produced in larger amounts and successfully freeze-dried. They kept their activity and showed they could work in complex reactions under harsh conditions, supporting their potential for industrial use.

"Beyond the obvious excitement of being able to generate truly de novo proteins, the results are a further testament to the ability of Basecamp Research's dataset to produce better results compared to publicly available datasets, which barely scratch the surface of the Earth's immense biodiversity," added Dr. Glen Gowers, co-founder of Basecamp Research. "Earlier we were able to show that our BaseFold model, also powered by our dataset, outperformed AlphaFold2 in predicting protein structures. Generative AI is going to have a huge impact across biotech, and we're dedicated to collecting the data and tools needed to make its potential a reality."

The full preprint can be found here: https://www.biorxiv.org/content/10.1101/2024.05.03.592223v1

Basecamp Research invites the research community to try ZymCTRL and has released it for public use on Hugging Face: https://huggingface.co/AI4PD/ZymCTRL

For media and other inquiries, please contact press@basecamp-research.com, +44 07867 488769

About Basecamp Research

Basecamp Research is a leader in mapping biodiversity for AI-based design of biological systems. We match and refine novel proteins for our partners' exact industrial, therapeutic or diagnostic applications using BaseGraph™, a new generation of AI design that is powered by the first-ever high-resolution map of global genetic biodiversity. 

Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. We're a team of explorers, scientists and policy experts driven by our ambition to protect and learn from nature's diversity, whilst delivering life-changing breakthroughs to those who need them most. 

For more information, visit www.basecamp-research.com.

Photo - https://mma.prnewswire.com/media/2439331/Basecamp_Research.jpg
Logo - https://mma.prnewswire.com/media/2357382/4763840/Basecamp_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.